Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy.

The pharmaceutical company announced it would be partnering with Hims & Hers., LifeMD and Ro. to provide all five dose strengths of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499. All doses will be delivered with a once-weekly single-dose pen.

Novo Nordisk's direct-to-consumer pharmacy, NovoCare® Pharmacy, was announced last month, meant for patients who are uninsured or on plans that don't cover obesity drugs.

The list........

© The Hill